ANALYST-UPGRADE filed Jul 21, 2026 at 06:09 ET
BMO Capital initiated coverage on INSM at Outperform with a $192 price target, implying 78.6% upside from the current $107.56. The firm has a 53% accuracy rate on 1,842 calls with a 2.3% average return, placing it in the middle tier among firms covering INSM. Consensus is overwhelmingly bullish, 28 of 29 analysts rate Buy or Strong Buy, with only 1 Hold and zero Sell ratings. The mean price target is $196.38, median $200, high $243, low $140. BMO's $192 target is slightly below the mean but still well above current levels. Momentum is positive: 1 upgrade and 0 downgrades in the last 30 days, though EPS revisions for the current fiscal year show 4 downward revisions vs 0 upward. Insider selling is notable, two C-suite members sold over $2.6M in July, but institutional buying is strong, with several funds adding or doubling positions. The initiation from a mid-tier firm adds modest bullish confirmation to an already crowded long consensus.